— New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also Being Evaluated in Ongoing Phase 2 Studies in the...
MANILA, Philippines, April 16, 2025 /PRNewswire/ -- The Philippine Heart Center has reached a significant milestone by successfully performing six Transcatheter Aortic Valve Implantation...
STOCKHOLM, April 16, 2025 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb), was named a 2025 Automotive News PACE Pilot Innovation to Watch at...
STOCKHOLM, April 16, 2025 /PRNewswire/ -- (NYSE: ALV) (SSE: ALIV.sdb) Q1 2025: Good sales and execution of cost reduction programs Financial highlights...